Study guide
Bacterial keratitis, sampling and treatment
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Bacterial keratitis, sampling and treatment
Key Takeaways Explain This Topic AI
A corneal infiltrate with an epithelial defect requires assessment of size, depth, location and perforation risk.
Severe or atypical keratitis needs appropriate microbiological sampling and prompt treatment without awaiting culture.
Steroids require a supported diagnosis and response; they must not turn suspected fungal or amoebic disease into routine bacterial treatment.
Last updated: October 2026
Infectious keratitis represents one of the most critical visual emergencies in anterior segment ophthalmology. The human cornea possesses an extraordinary anatomic and immunological defense system: an intact non-keratinised stratified squamous epithelium secured by tight junctions ( zonula occludens ), a basement membrane, an acellular Bowman layer, an avascular stroma populated by quiescent keratocytes and uniformly spaced collagen fibrils, Descemet membrane, and a single monolayer of metabolic endothelium. Disruption of the epithelial barrier permits microbial adhesion, invasion, and inflammatory destruction.
Only a select group of virulent microorganisms can penetrate an intact, healthy corneal epithelium :
- Neisseria gonorrhoeae
- Neisseria meningitidis
- Corynebacterium diphtheriae
- Listeria monocytogenes
- Haemophilus aegyptius (Koch-Weeks bacillus)
All other pathogens require an epithelial breach—induced by contact lens wear, mechanical microtrauma, foreign bodies, bullous keratopathy, dry eye disease, trichiasis, or neurotrophic hypoesthesia—to establish stromal infection.
1. Bacterial Keratitis: Pathogen Profiles & Biomicroscopic Morphology
Bacterial keratitis progresses with alarming speed. Bacteria liberate endotoxins, exotoxins, and proteases, inciting an intense host polymorphonuclear neutrophil (PMN) infiltration that degrades stromal collagen and proteoglycans, precipitating stromal melting and corneal perforation.
Major Pathogen Profiles
Pseudomonas aeruginosa : The most devastating pathogen associated with soft contact lenses (especially extended/overnight wear). A Gram-negative, aerobic, motile rod that elaborates Exotoxin A (inhibiting host protein synthesis via elongation factor 2 ADP-ribosylation), elastase, and a Type III secretion system (ExoU cytotoxin causing rapid cellular lysis). Slit-lamp biomicroscopy reveals a dense "ground-glass" stromal haze, copious yellowish-green mucopurulent discharge (pyocyanin pigment), rapid liquefactive stromal necrosis capable of complete corneal melting and perforation within 24 to 48 hours, and an immune ring infiltrate (Wessely ring) formed by antigen-antibody complex precipitation.
Staphylococcus aureus (including MRSA) : Gram-positive cocci in clusters. Characteristically produces a distinct, round, focal white-yellow stromal infiltrate with distinct, well-demarcated margins, minimal surrounding stromal spread, and microabscesses.
Streptococcus pneumoniae : Gram-positive lancet-shaped diplococci. Typically produces a creeping, serpiginous ulcer with an undermined, advancing necrotic border and extensive deep stromal necrosis accompanied by an early, massive sterile hypopyon in the anterior chamber.
Moraxella lacunata : Gram-negative diplobacilli. Tends to cause an indolent, oval, paracentral or inferior stromal ulcer with slow progression, seen predominantly in elderly, malnourished, alcoholic, or immunosuppressed patients.
2. Corneal Diagnostic Workup: Scraping Protocol & Culture Media
Every corneal ulcer that is central, large ( > 1.5 – 2.0 mm > 1.5–2.0\text{ mm} > 1.5–2.0 mm ), deep ( > 50 % > 50\% > 50% stromal depth), vision-threatening, or recalcitrant to initial therapy requires immediate corneal scraping for microscopy and culture prior to initiating antimicrobial drops.
Scraping Protocol
Instil preservative-free topical anaesthetic (proxymetacaine 0.5% or proparacaine 0.5%). Avoid anaesthetics with bacteriostatic preservatives such as benzalkonium chloride (BAK), which inhibit microbial growth on agar.
Under direct slit-lamp visualisation, use a sterilised platinum Kimura spatula, a 21-gauge sterile needle, or a sterile surgical blade (#15) to scrape the advancing border and base of the ulcer. Avoid necrotic slough, which contains dead neutrophils rather than viable organisms.
Inoculate solid media using gentle "C-streaks" without breaking the agar surface. Inoculate liquid broths directly.
Primary Diagnostic Stains and Culture Media
Diagnostic Tool / Medium Target Organisms Incubation & Diagnostic Features
Gram Stain Bacteria, Yeasts Gram-positive (purple) vs Gram-negative (pink) differentiation; yeasts appear as large budding oval Gram-positive cells
Giemsa Stain Bacteria, Fungi, Acanthamoeba , Cytology Highlights fungal hyphae, amoebic trophozoites/cysts, and reveals neutrophil vs eosinophil infiltration
Calcofluor White / 10% KOH Fungi, Acanthamoeba Fluorescent optical brightener binding chitin and cellulose; rapidly visualises fungal hyphae and double-walled amoebic cysts under UV illumination
Blood Agar (5% Sheep) Aerobic & facultative anaerobic bacteria, saprophytic fungi Incubated at 35 ∘ C 35^\circ\text{C} 3 5 ∘ C ; evaluates haemolysis patterns ( α , β , γ \alpha, \beta, \gamma α , β , γ )
Chocolate Agar Neisseria , Haemophilus , Moraxella Incubated at 35 ∘ C 35^\circ\text{C} 3 5 ∘ C in 5 – 10 % CO 2 5–10\%\text{ CO}_2 5–10% CO 2 ; boiled blood releases factors X (haemin) and V (NAD)
Sabouraud Dextrose Agar (SDA) Filamentous fungi & yeasts Incubated at 25 – 30 ∘ C 25–30^\circ\text{C} 25–3 0 ∘ C ; acidic pH ( 5.6 5.6 5.6 ) with chloramphenicol to suppress bacterial overgrowth
Cooked Meat / Thioglycollate Broth Anaerobic bacteria Incubated at 35 ∘ C 35^\circ\text{C} 3 5 ∘ C ; isolates Cutibacterium acnes , Clostridium , and Bacteroides species
Non-Nutrient Agar (NNA) + E. coli Acanthamoeba Covered with heat-killed Escherichia coli ; amoebic trophozoites ingest bacteria, leaving visible cleared tracks on agar
- 3. Antimicrobial Pharmacotherapy for Bacterial Keratitis
- Fortified Topical Antibiotics
For severe, central, deep or rapidly progressive bacterial keratitis, obtain appropriate microbiological samples promptly and start intensive treatment without waiting for culture results. Empirical treatment may use a suitable fluoroquinolone or fortified combination according to severity, local susceptibility, prior treatment and specialist protocol. Fortified vancomycin and ceftazidime are useful options in selected cases, not a mandatory universal pair for every ulcer. Review response closely and adjust to the organism and sensitivity results.
Gram-Positive Coverage : Fortified Vancomycin 50 mg/mL (5%) or Cefuroxime/Cefazolin 50 mg/mL. Vancomycin provides bactericidal coverage against Methicillin-Resistant Staphylococcus aureus (MRSA), coagulase-negative staphylococci, and penicillin-resistant Streptococcus pneumoniae .
Gram-Negative Coverage : Fortified Ceftazidime 50 mg/mL (5%) or Amikacin/Tobramycin 14 mg/mL (1.4%). Ceftazidime provides excellent coverage against Pseudomonas aeruginosa without the epithelial toxicity seen with prolonged aminoglycoside administration.
Intensive Dosing Schedule
Loading Phase : One drop every 5 minutes for the first 30 minutes.
Induction Phase : One drop alternating every 15 to 30 minutes round-the-clock for the initial 24 to 48 hours.
Consolidation Phase : Gradual tapering according to objective clinical response: re-epithelialisation, blunting of infiltrate borders, reduction in stromal oedema, and clearance of anterior chamber hypopyon.
Monotherapy with Fluoroquinolones
Fluoroquinolone monotherapy can be appropriate in selected bacterial ulcers, including some more substantial lesions, according to susceptibility and local protocol. Severity, location, progression and clinical response determine escalation; there is no universal peripheral-size-only rule.
Important
SCUT found no overall three-month acuity benefit from adjunctive topical steroids in culture-positive bacterial ulcers after initial antibiotic therapy. Subgroup findings suggest possible benefit in selected severe/central disease, but do not create a universal steroid indication. Confirm an appropriate bacterial diagnosis and response before considering steroids; avoid treating suspected fungal or amoebic infection as routine bacterial inflammation.